APA 6th Edition Husar, D. i Đelmiš, J. (2008). TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI. Gynaecologia et perinatologia, 17 (2), 77-82. Preuzeto s https://hrcak.srce.hr/62099
MLA 8th Edition Husar, Darko i Josip Đelmiš. "TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI." Gynaecologia et perinatologia, vol. 17, br. 2, 2008, str. 77-82. https://hrcak.srce.hr/62099. Citirano 23.01.2020.
Chicago 17th Edition Husar, Darko i Josip Đelmiš. "TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI." Gynaecologia et perinatologia 17, br. 2 (2008): 77-82. https://hrcak.srce.hr/62099
Harvard Husar, D., i Đelmiš, J. (2008). 'TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI', Gynaecologia et perinatologia, 17(2), str. 77-82. Preuzeto s: https://hrcak.srce.hr/62099 (Datum pristupa: 23.01.2020.)
Vancouver Husar D, Đelmiš J. TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI. Gynaecologia et perinatologia [Internet]. 2008 [pristupljeno 23.01.2020.];17(2):77-82. Dostupno na: https://hrcak.srce.hr/62099
IEEE D. Husar i J. Đelmiš, "TROMBOEMBOLIJSKA BOLEST U TRUDNOĆI", Gynaecologia et perinatologia, vol.17, br. 2, str. 77-82, 2008. [Online]. Dostupno na: https://hrcak.srce.hr/62099. [Citirano: 23.01.2020.]
Sažetak SUMMARY. Fatal pulmonary embolism remains the most common cause of mortality among pregnant women in many Western countries. About high risk for venous thromboembolism during pregnancy we know for centuries. The physiological changes of pregnancy produce a hypercoagulable state that increases the risk of venous thromboembolism (VTE). Women with inherited or acquired thrombophilias are at particulary high risk of VTE during pregnancy, and throm¬boprophylaxis may be advisable in some cases. Thrombophilia is also associated with complications of pregnancy, including fetal loss, pre-ecclampsia, intra-uterine growth restriction, and placental abruption. The antithrombotic agents available for the prevention and treatment of VTE during pregnancy, and pregnancy complications, include unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and aspirin. Vitamin K antagonists are contraindicated in pregnancy. The efficacy and safety of LMWH have been demonstrated for the prevention and treatment of the VTE in pregnancy. LMWH is today therapy of the choice for VTE and its complications in pregnancy. LMWH replaced UFH ¬because of its higher security and less side effects.